Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
01.10.25
/
50%
€115.08
Target price
01.10.26
€133.73
Performance (%)
-6.22%
Price
16:46
€107.92
Summary
This prediction is currently active. With a performance of -6.22%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 01.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 4.194% | 4.194% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $153.00 to $157.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€133.42
04.03.25
04.03.25
€146.25
04.03.26
04.03.26
-19.11%
16:46
16:46
